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R106Bacterial Invasion: Linking Autophagy
and Innate ImmunityCrohn’s disease is a chronic inflammatory bowel disorder that has been
associated with polymorphisms in the genes encoding the pattern-recognition
receptor NOD2 and the autophagic regulator ATG16L1. A new study
demonstrates that NOD2 recruits ATG16L1 at bacterial entry sites, thereby
bridging innate immunity and autophagy.Lorenzo Galluzzi1,2,3, Oliver Kepp1,2,3,
Laurence Zitvogel2,3,4,
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The etiology of chronic inflammatory
disorders of the bowel, such as Crohn’s
disease, is largely unknown; however,
recent epidemiological studies have
suggested the existence of a strong
genetic predisposition interacting with
hitherto undetermined environmental
triggers to render susceptible
individuals at risk. More than 30
distinct loci have indeed been
involved in the genetic susceptibility
to Crohn’s disease, including genes
implicated in autophagy, maintenance
of epithelial barrier integrity, innate
immunity, and secondary immune
responses [1]. In particular, Crohn’s
disease has been associated with
polymorphisms affecting the essential
autophagic modulator ATG16L1 and
the pattern-recognition receptor (PRR)
NOD2 [2]. Although both ATG16L1 and
NOD2 had previously been shown to be
required for the proper recognition and
disposal of intracellular pathogens
(including enteric bacteria that may
contribute to the etiology of Crohn’s
disease) [3,4], until recently a
mechanistic link between these
proteins was missing. Now, Travassos
et al. [5] have demonstrated that NOD2
recruits ATG16L1 at the plasma
membrane of infected cells to activate
the generation of autophagosomes
around invading bacteria, thereby
pointing to a functional link between
autophagy and innate immunity that
is critical for the etiology of Crohn’s
disease.
Autophagy is a finely regulated,
evolutionarily conserved multi-step
process by which damaged,
supernumerary or ectopic intracellular
entities are sent to lysosomes for
degradation [6]. While in a few
experimental settings autophagy may
contribute to cell death [7,8], in most
circumstances autophagy constitutes
a cytoprotective mechanism that isactivated in response to a wide range
of stressful conditions [9]. Moreover,
baseline levels of autophagy have
been shown to be required for the
maintenance of intracellular
homeostasis — for instance, by
preventing the accumulation of
aggregate-prone proteins or
uncoupled (and hence potentially
dangerous) mitochondria — and to
exert oncosuppressive functions [10].
Thus, the autophagic pathway has
been implicated in human disorders as
different as neurodegeneration,
cancer, aging and infectious diseases
[2]. In particular, autophagy has
emerged as a critical mechanism of
host defense against viral, bacterial
and parasitic infections (in this context,
it has been dubbed ‘xenophagy’), and
defective autophagy has been linked
to increased susceptibility to infectious
diseases, both in vitro and in vivo [11].
During the initial phase of autophagy,
an isolation membrane that
presumably derives from the
endoplasmic reticulum begins to
surround the cytosolic material to be
degraded. This process can occur in
a relatively non-specific fashion, for
instance when the autophagic pathway
is triggered by nutrient deprivation
(and hence is aimed at generating
novel substrates to meet the cell’s
energetic/anabolic demands), or it
can be highly specific, for instance
in response to pathogen invasion [12].
Multiple AuTophaGy-related (ATG)
proteins, including the well-known
ATG6/Beclin-1 and ATG8/LC3, are
required for the correct execution of the
autophagic program [12]. ATG16L1
also represents an essential autophagy
modulator, as demonstrated by the
fact that ATG16L1-deficient mice die
in the first day of life (similar to atg52/2
and atg72/2 animals), presumably due
to their inability to adapt to early
postnatal starvation by activating
autophagy [13]. ATG16L1-deficient
cells are characterized by ineffective
recruitment of the ATG5–ATG12complex to the isolation membrane,
and hence by an overall impairment
of the autophagic machinery [13].
The Crohn’s disease-associated
atg16l1 risk allele encodes a protein
with a threonine-to-alanine substitution
(T300A) in its carboxy-terminal domain,
which contains tryptophan-aspartate
(WD) repeats [4]. Although this
domain of ATG16L1 is not conserved
and is actually dispensable for the
ATG16L1-dependent recruitment of
ATG5–ATG12 complexes, as well as
for starvation-induced autophagy, the
ATG16L1 T300A mutant may exhibit a
reduced stability and therefore fail
to localize the autophagic machinery to
invading bacteria [4]. This hypothesis
is supported by the observation that
ATG16L1-hypomorphic mice
(generated by the intronic insertion
of a gene-trap vector within atg16l1)
normally develop into adulthood, yet
progressively accumulate histological
abnormalities in the bowel that
closely resemble changes in the ileum
from those patients with Crohn’s
disease who are homozygous for
the allele encoding the T300A ATG16L1
mutant [14]. Notably, in both settings,
Paneth cells, which normally provide
a barrier to bacterial invasion by
secreting antimicrobial products,
exhibit morphological and
ultrastructural alterations, and, in
ATG16L1-hypomorphic animals,
these cells lose the capacity to
secrete the antimicrobial peptide
lysozyme into the intestinal lumen
[14]. This suggests that defects in the
molecular machinery for autophagy
may contribute to Crohn’s disease by
affecting distinct cell types of the
bowel, including local macrophages
and Paneth cells.
In macrophages, the absence of
ATG16L1 has been associated with
enhanced cytokine production in
response to ligation of Toll-like
receptors (TLRs) [13], which are known
to act as PRRs and therefore play a
prominent role in innate immunity.
PRRs, which include (but are not
limited to) NODs and TLRs, are
characterized by the ability to
recognize invading pathogens as well
as other ‘danger signals’ and directly
activate specific signal transduction
pathways that alert host defenses [15].
Such biochemical cascades may vary
depending on both cell-extrinsic and
cell-intrinsic variables, including cell
type and initiating stimulus. Thus, in
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Figure 1. Schematic outline of the alterations that affect the NOD2–ATG16L1 signaling axis and xenophagy in Crohn’s disease.
(A) Normal intestinal epithelium. Paneth cells react to pathogens by efficiently secreting antimicrobial products into the intestinal lumen. In addi-
tion, local macrophages mount a proficient xenophagic response mediated by the interaction between NOD2 and ATG16L1 at bacterial entry
sites, resulting in the recruitment and activation of ATG5–ATG12 complexes. (B) Epithelium at risk for Crohn’s disease. ATG16L1-deficient Pan-
eth cells exhibit ultrastructural alterations and (at least partially) lose the capacity to secrete antimicrobial peptides into the intestinal lumen in
response to infection. Although the ATG16L1 T300A mutant retains the ability to recruit ATG5–ATG12 complexes, it displays a reduced stability
and therefore fails to actively localize the autophagic machinery to invading bacteria. Similarly, the xenophagic response to intracellular path-
ogens is highly inefficient in macrophages that express the NOD2FS variant, as NOD2FS prevents ATG16L1 from localizing at bacterial entry
sites by retaining it in the cytoplasm.
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R107non-myeloid cells infected by Shigella
flexneri, NOD1 can activate the
pro-inflammatory transcription factor
NF-kB (via the receptor-interacting
kinase RIP2) or can elicit a regulated
form of necrosis (necroptosis, which
also has inflammatory outcomes) [16].
Similarly, NOD2 has been shown to
respond to bacterial products by
triggering a RIP2-dependent signal
transduction cascade that eventually
results in NF-kB activation [17].
Consistent with the critical role of
NODs in innate immunity, both nod12/2
and nod22/2 mice exhibit an increased
susceptibility to infection by
intracellular bacteria [18,19]. The
most prevalent nod2 polymorphism
in Crohn’s disease is L1007insC,
resulting in a truncated NOD2 protein
(NOD2FS) that fails to activate NF-kB
in response to peptidoglycan [20].
Altogether, these observations
suggested that both autophagy and
innate immunity are involved in thepathogenesis of Crohn’s disease, and
strongly pointed to some kind of
cooperation between these processes,
yet the molecular nature of this
crosstalk was elusive. This gap has
now been filled by Travassos and
colleagues [5], who have demonstrated
that peptidoglycan sensing is
functionally connected to the initiation
of autophagy thanks to the interaction
betweenNODs andATG16L1 (Figure 1).
In a variety of experimental settings
(including ‘classical’ human cancer
cell lines, nod12/2 and nod22/2 mice,
as well as immortalized cells derived
from Crohn’s disease patients), these
authors have demonstrated that
NOD1 and NOD2 are critical for the
autophagic response to invasive
bacteria because they recruit ATG16L1
to bacterial entry sites at the plasma
membrane. The interaction between
NODs and ATGL16L1 (and the
consequent induction of autophagy)
persisted in rip22/2 mouse embryonicfibroblasts challenged with S. flexneri,
suggesting that NODs mediate
autophagy independent of NF-kB [5].
Most importantly, the authors found
that the Crohn’s disease-associated
truncated variant of NOD2 (NOD2FS,
which unlike its wild-type counterpart
is localized exclusively to the
cytoplasm) fails to recruit ATG16L1
to the plasma membrane upon
infection with intracellular bacteria.
Co-immunoprecipitation assays
revealed that, similar to wild-type
NOD2, NOD2FS retains the ability
to bind ATG16L1. However, in
NOD2FS-expressing cells, ATG16L1
failed to relocalize to the sites of
bacterial invasion, suggesting that
NOD2FS might suppress the
autophagy-modulatory functions
of ATG16L1 by retaining it in the
cytoplasm and hence preventing
it from localizing at the plasma
membrane. Accordingly, macrophages
derived from the bone marrow of
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NOD2 mutation corresponding to the
human Crohn’s disease-associated
L1007insC mutation displayed a
striking xenophagy defect in
response to S. flexneri infection [5].
Taken together, the results by
Travassos et al. [5] establish a
mechanistic link between modulators
of innate immunity (i.e., NODs) and
the cellular machinery for autophagy
(and ATG16L1 in particular), which
cooperate in the control of bacterial
invasion. Thus, the NOD2–ATG16L1
axis appears for the first time as a
unique pathway, the deregulation of
which plays a central role in the etiology
of Crohn’s disease, with obvious
therapeutic implications. Future
investigations will have to elucidate
whether the products of other loci
that have been associated with
Crohn’s disease also interact with the
molecular machinery for xenophagy.
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RNA WorldMicroRNAs are believed to control many physiological processes in animals.
Now, two studies show that some of their presumptive functions are actually
fulfilled by another class of RNAs — siRNAs.Herve´ Seitz
Three classes of small regulatory
RNAs are known in animals:
microRNAs (miRNAs), small interfering
RNAs (siRNAs) and Piwi-interacting
RNAs (piRNAs). The first two classes
share common features: they are
loaded on the same effector proteins
(the Ago subfamily of the ‘Argonaute’
protein family) and they are generated
by the cleavage of double-stranded
RNA by nucleases of the RNase III
family. ButmiRNAs and siRNAs differ in
their biogenesis (Figure 1): while bothclasses are processed by a nuclease
called ‘Dicer’, the biogenesis of most
miRNAs also involves an enzyme called
‘Drosha’ (and its partner protein,
Dgcr8).
miRNAs were discovered earlier
than siRNAs (in mammals, endogenous
siRNAs were uncovered two years ago
[1–3], seven years later than miRNAs
[4]). Therefore, microRNAs have been
more extensively studied: before their
siRNA cousins were even discovered,
miRNAs had been implicated in a broad
range of biological processes, notably
in the control of development (reviewedin [5]). Mammalian siRNAs have been
shown to repress transposable
elements and a few non-transposable
genes (far less than miRNA-regulated
genes) [1,2].
In this light, the strong phenotypic
defects of Dicer-defective mice [6]
were usually interpreted as a
consequence of their lack of miRNAs.
The recent discovery of endogenous
siRNAs could challenge this belief: as
Dicer participates in the biogenesis of
both miRNAs and siRNAs (Figure 1),
these defects could actually be due to
a lack of siRNAs. Two papers in this
issue of Current Biology indeed show
that the observed defects in mouse
oocyte development must be due to
siRNAs [7,8].
In order to sort out the contribution of
miRNAs and siRNAs to the spectacular
phenotypes of Dicer-deficient oocytes,
Suh and collaborators [7] prepared a
conditional knock-out of Dgcr8. While
